Literature DB >> 19640558

Kaposi sarcoma-associated herpes virus (KSHV) G protein-coupled receptor (vGPCR) activates the ORF50 lytic switch promoter: a potential positive feedback loop for sustained ORF50 gene expression.

Virginie Bottero1, Neelam Sharma-Walia, Nagaraj Kerur, Arun George Paul, Sathish Sadagopan, Mark Cannon, Bala Chandran.   

Abstract

KSHV vGPCR, a lytic cycle associated protein, induces several signaling pathways leading to the activation of various transcription factors and consequently the expression of cellular and viral genes. Though the role of vGPCR in KSHV tumorigenicity has been well studied, its function related to the viral life cycle is poorly understood. Reduction in vGPCR by RNA interference also resulted in the reduction in KSHV lytic switch ORF50 gene and protein expression. Induction of vGPCR by doxycycline in BC3.14 cells also resulted in more KSHV production. When this was explored, induction of the ORF50 promoter by vGPCR expression was observed. Further examination of the molecular mechanisms by which vGPCR regulates the ORF50 promoter, using various ORF50 promoter constructs, revealed that induction of ORF50 promoter by vGPCR did not involve AP1 but was dependent on Sp1 and Sp3 transcription factors. vGPCR signaling led to an increase in Sp1 and Sp3 DNA binding activity and a decrease in histone deacetylase (HDAC) activity. These activities were pertussis toxin independent, did not involve Rho and Rac-GTPases and involved the heterotrimeric G protein subunits Galpha12 and Galphaq. Studies using pharmacologic inhibitors and dominant-negative proteins identified phospholipase C, the novel protein kinase C (novel PKC) family and protein kinase D (PKD) as part of the signaling initiated by vGPCR leading to ORF50 promoter activation. Taken together, this study suggests a role for vGPCR in the sustained expression of ORF50 which could lead to a continued activation of lytic cycle genes and ultimately to successful viral progeny formation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19640558      PMCID: PMC2747482          DOI: 10.1016/j.virol.2009.07.002

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  99 in total

1.  Disruption of the gene encoding the gammaHV68 v-GPCR leads to decreased efficiency of reactivation from latency.

Authors:  Nathaniel J Moorman; Herbert W Virgin; Samuel H Speck
Journal:  Virology       Date:  2003-03-15       Impact factor: 3.616

2.  The Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor has broad signaling effects in primary effusion lymphoma cells.

Authors:  Mark Cannon; Nicola J Philpott; Ethel Cesarman
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

3.  Endothelial infection with KSHV genes in vivo reveals that vGPCR initiates Kaposi's sarcomagenesis and can promote the tumorigenic potential of viral latent genes.

Authors:  Silvia Montaner; Akrit Sodhi; Alfredo Molinolo; Thomas H Bugge; Earl T Sawai; Yunsheng He; Yi Li; Patricio E Ray; J Silvio Gutkind
Journal:  Cancer Cell       Date:  2003-01       Impact factor: 31.743

4.  A gammaherpesvirus G protein-coupled receptor homologue is required for increased viral replication in response to chemokines and efficient reactivation from latency.

Authors:  Bong Joo Lee; Ulrich H Koszinowski; Sally R Sarawar; Heiko Adler
Journal:  J Immunol       Date:  2003-01-01       Impact factor: 5.422

5.  Kaposi's sarcoma associated herpesvirus G protein-coupled receptor immortalizes human endothelial cells by activation of the VEGF receptor-2/ KDR.

Authors:  Carlos Bais; Albert Van Geelen; Pilar Eroles; Agata Mutlu; Chiara Chiozzini; Sergio Dias; Roy L Silverstein; Shahin Rafii; Enrique A Mesri
Journal:  Cancer Cell       Date:  2003-02       Impact factor: 31.743

Review 6.  Molecular genetics of Kaposi's sarcoma-associated herpesvirus (human herpesvirus-8) epidemiology and pathogenesis.

Authors:  Lyubomir A Dourmishev; Assen L Dourmishev; Diana Palmeri; Robert A Schwartz; David M Lukac
Journal:  Microbiol Mol Biol Rev       Date:  2003-06       Impact factor: 11.056

7.  Lytic but not latent infection by Kaposi's sarcoma-associated herpesvirus requires host CSL protein, the mediator of Notch signaling.

Authors:  Yuying Liang; Don Ganem
Journal:  Proc Natl Acad Sci U S A       Date:  2003-06-27       Impact factor: 11.205

8.  Comparative study of regulation of RTA-responsive genes in Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8.

Authors:  Moon Jung Song; Hongyu Deng; Ren Sun
Journal:  J Virol       Date:  2003-09       Impact factor: 5.103

9.  CCAAT/enhancer-binding protein-alpha is induced during the early stages of Kaposi's sarcoma-associated herpesvirus (KSHV) lytic cycle reactivation and together with the KSHV replication and transcription activator (RTA) cooperatively stimulates the viral RTA, MTA, and PAN promoters.

Authors:  Shizhen Emily Wang; Frederick Y Wu; Yanxing Yu; Gary S Hayward
Journal:  J Virol       Date:  2003-09       Impact factor: 5.103

10.  Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) contains hypoxia response elements: relevance to lytic induction by hypoxia.

Authors:  Muzammel Haque; David A Davis; Victoria Wang; Isabelle Widmer; Robert Yarchoan
Journal:  J Virol       Date:  2003-06       Impact factor: 5.103

View more
  22 in total

1.  Kaposi's sarcoma-associated herpesvirus interacts with EphrinA2 receptor to amplify signaling essential for productive infection.

Authors:  Sayan Chakraborty; Mohanan Valiya Veettil; Virginie Bottero; Bala Chandran
Journal:  Proc Natl Acad Sci U S A       Date:  2012-04-16       Impact factor: 11.205

2.  Cell membrane-bound Kaposi's sarcoma-associated herpesvirus-encoded glycoprotein B promotes virus latency by regulating expression of cellular Egr-1.

Authors:  Ossie F Dyson; Christopher M Traylen; Shaw M Akula
Journal:  J Biol Chem       Date:  2010-09-23       Impact factor: 5.157

3.  The Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor: Lessons on dysregulated angiogenesis from a viral oncogene.

Authors:  Bruno C Jham; Silvia Montaner
Journal:  J Cell Biochem       Date:  2010-05       Impact factor: 4.429

4.  Virus reactivation: a panoramic view in human infections.

Authors:  Christopher M Traylen; Hersh R Patel; Wylder Fondaw; Sheran Mahatme; John F Williams; Lia R Walker; Ossie F Dyson; Sergio Arce; Shaw M Akula
Journal:  Future Virol       Date:  2011-04       Impact factor: 1.831

Review 5.  Viral G Protein-Coupled Receptors Encoded by β- and γ-Herpesviruses.

Authors:  Mette M Rosenkilde; Naotaka Tsutsumi; Julius M Knerr; Dagmar F Kildedal; K Christopher Garcia
Journal:  Annu Rev Virol       Date:  2022-06-07       Impact factor: 14.263

Review 6.  Hijacking GPCRs by viral pathogens and tumor.

Authors:  Junjie Zhang; Hao Feng; Simin Xu; Pinghui Feng
Journal:  Biochem Pharmacol       Date:  2016-04-06       Impact factor: 5.858

Review 7.  KSHV: pathways to tumorigenesis and persistent infection.

Authors:  Louise Giffin; Blossom Damania
Journal:  Adv Virus Res       Date:  2014       Impact factor: 9.937

8.  Rapamycin blocks production of KSHV/HHV8: insights into the anti-tumor activity of an immunosuppressant drug.

Authors:  Lisa A Nichols; Laura A Adang; Dean H Kedes
Journal:  PLoS One       Date:  2011-01-14       Impact factor: 3.240

Review 9.  KSHV reactivation and novel implications of protein isomerization on lytic switch control.

Authors:  Jonathan Guito; David M Lukac
Journal:  Viruses       Date:  2015-01-12       Impact factor: 5.048

10.  EphrinA2 regulates clathrin mediated KSHV endocytosis in fibroblast cells by coordinating integrin-associated signaling and c-Cbl directed polyubiquitination.

Authors:  Dipanjan Dutta; Sayan Chakraborty; Chirosree Bandyopadhyay; Mohanan Valiya Veettil; Mairaj Ahmed Ansari; Vivek Vikram Singh; Bala Chandran
Journal:  PLoS Pathog       Date:  2013-07-18       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.